Pyoderma: Resistant Infections & the Role of Antimicrobials

The rising prevalence of methicillin-resistant Staphylococcus pseudintermedius (MRSP) has transformed veterinary dermatology, shifting topical therapy from an adjunctive treatment to a primary cornerstone of care. Topical agents, offer direct pathogen targeting with significant residual activity and minimal systemic side effects. Furthermore, managing the skin barrier with ingredients like ceramides and Ophytrium is essential for long-term control of recurrent infections in allergic dogs. By prioritizing culture-based diagnostics and aggressive topical protocols, clinicians can practice effective antibiotic stewardship while successfully managing complex, multidrug-resistant pyoderma. New international guidelines on antimicrobial stewardship will also be discussed.

• Identify the molecular basis of methicillin resistance in Staphylococcus species and the clinical risk factors.
• Evaluate the efficacy and residual activity of various topical antiseptics.
• Implement ISCAID guidelines for bacterial culture and sensitivity testing to ensure appropriate antibiotic stewardship in cases of recurrent or non-responsive infections.
• Integrate barrier-repair ingredients and innovative non-pharmacologic options, like the Phovia system, into long-term maintenance protocols for atopic patients